Early serum S100β but not neuron-specific enolase reflects baseline CNS vulnerability in ICANS after CD19 CAR T-cell therapy

Journal of Neurology 2026

View at publisher
Authors: Charleen Robert, Dimitri Psimaras, Sylvain Choquet, Dominique Bonnefont-Rousselot, Rana Alkouri, Mehdi Sakka, Jérôme Alexandre Denis, Clémence Marois, Caroline Houillier, Cristina Birzu, Alice Leprince, Damien Ricard
+15 more Véronique Morel, Madalina Uzunov, Laëtitia Souchet, Ines Boussen, Marine Baron, Damien Roos-Weil, Valérie Friser, Nathalie Miranda, Natalia Shor, Delphine Leclercq, Maxens Decavèle, Benjamin Rohaut, Sophie Demeret, Nicolas Weiss, Loïc Le Guennec
DOI: 10.1007/s00415-026-13698-0
Cited by: 1
References: 16

Fields of Study & Subjects

CAR-T cell therapy research Cancer Immunotherapy and Biomarkers Autoimmune Neurological Disorders and Treatments

Publication details

Journal / source
Journal of Neurology
Publisher
Springer Science and Business Media LLC
Volume
273
Issue
2
Pages
148–148
Publication date
1 February 2026
Language
EN